|
1
|
Assari R, Ziaee V, Parvaneh N and
Moradinejad MH: Periodic fever and neutrophilic dermatosis, Is it
Sweet's syndrome? Case Reports Immunol. 2014:3209202014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Prat L, Bouaziz JD, Wallach D,
Vignon-Pennamen MD and Bagot M: Neutrophilic dermatoses as systemic
diseases. Clin Dermatol. 32:376–388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thompson MA, Dyson SW and Faderl S:
Sweet's syndrome in chronic lymphocytic leukemia associated with
neutropenic fever and granulocyte colony-stimulation factor. Am J
Hematol. 81:703–705. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sweet RD: An acute febrile neutrophilic
dermatosis. Br J Dermatol. 76:349–356. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen PR: Sweet's syndrome - a
comprehensive review of an acute febrile neutrophilic dermatosis.
Orphanet J Rare Dis. 2:342007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dabade TS and Davis MD: Diagnosis and
treatment of the neutrophilic dermatoses (pyoderma gangrenosum
Sweet's syndrome). Dermatol Ther. 24:273–284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guhl G and Garcia-Diez A: Subcutaneous
Sweet syndrome. Dermatol Clin. 26:541–551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhandari PR and Pai VV: Novel applications
of rituximab in dermatological disorders. Indian Dermatol Online J.
5:250–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cullity J, Maguire B and Gebauer K:
Sweet's panniculitis. Australas J Dermatol. 32:61–64. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Usul Afşar C, Paydaş S, Günaldi M, Bozkurt
Duman B, Erçolak V, Zorludemir S and Açikalin A: Sweet syndrome in
a patient with chronic lymphocytic leukemia/small lymphocytic
lymphoma: Curious lymphocyte/neutrophil fluctuations. Turk J
Haematol. 30:413–415. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cholongitas E, Pipili C, Dasenaki M and
Kaklamanis L: Piperacillin/tazobactam-induced Sweet syndrome in a
patient with chronic lymphocytic leukemia and autoimmune
cholangitis. Am J Dermatopathol. 30:203–204. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tageja N, Giorgadze T and Zonder J:
Dermatological complications following initiation of lenalidomide
in a patient with chronic lymphocytic leukaemia. Intern Med J.
41:286–288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reuss-Borst MA, Müller CA and Waller HD:
The possible role of G-CSF in the pathogenesis of Sweet's syndrome.
Leuk Lymphoma. 15:261–264. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cohen PR: Neutrophilic dermatoses: A
review of current treatment options. Am J Clin Dermatol.
10:301–312. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lipsker D, Perrigouard C, Foubert A and
Cribier B: Anakinra for difficult-to-treat neutrophilic
panniculitis, IL-1 blockade as a promising treatment option for
neutrophil-mediated inflammatory skin disease. Dermatology.
220:264–267. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kluger N, Gil-Bistes D, Guillot B and
Bessis D: Efficacy of anti-interleukin-1 receptor antagonist
anakinra (Kineret®) in a case of refractory Sweet's syndrome.
Dermatology. 222:123–127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Delluc A, Limal N, Puéchal X, Francès C,
Piette JC and Cacoub P: Efficacy of anakinra, an IL1 receptor
antagonist, in refractory Sweet syndrome. Anne Rheum Dis.
67:278–279. 2008. View Article : Google Scholar
|
|
18
|
Karamlou K and Gorn AH: Refractory Sweet
syndrome with autoimmune organizing pneumonia treated with
monoclonal antibodies to tumor necrosis factor. J Clin Rheumatol.
10:331–335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gill HH, Leung AY, Trendell-Smith NJ,
Yeung CK and Liang R: Sweet syndrome due to myelodysplastic
syndrome, Possible therapeutic role of intravenous immunoglobulin
in addition to standard treatment. Adv Hematol. 2010:3283162010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haliasos E, Soder B, Rubenstein DS,
Henderson W and Morrell DS: Pediatric Sweet syndrome and
immunodeficiency successfully treated with intravenous
immunoglobulin. Pediatr Dermatol. 22:530–535. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lobo AM, Stacy R, Cestari D, Stone JH,
Jakobiec FA and Sobrin L: Optic nerve involvement with panuveitis
in Sweet syndrome. Ocul Immunol Inflamm. 19:167–170. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schafranski MD, Merlini AB, Hungaro AC,
Luciano JJ and Schumacher MS: Rituximab: Update on pharmacology and
clinical applications.
|
